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Abstract: Quantum dots (QDs) have shown great development potential in noninvasive imaging 
and monitoring of cancer cells in vivo because of their unique optical properties. However, the 
key issue of whether or not QDs-labeled cancer cells affect the proliferation, apoptosis and in 
vivo tumorigenicity ability has not been reported. The primary issue is if the results obtained 
from the noninvasive visualization of QDs-labeled tumors are scientific. Here, we applied 
peptide-linked near-conjugated fluorescent QDs to label human buccal squamous cell carcinoma 
cell line (BcaCD885). We performed in vivo tumorigenicity ability assays, tumorigenic cells 
proliferation, and apoptotic capability assays detected by flow cytometry and plate clone forma-
tion experiment, and found that peptide-linked near-conjugated fluorescent QDs labeling did 
not affect the growth, proliferation, apoptosis, and tumorigenicity ability of those cancer cells. 
Our study provides scientific foundation to support the application of near-infrared fluorescent 
QDs in noninvasive imaging and monitoring of cancer cells in vivo.
Keywords: quantum dots, near-infrared fluorescence, oral cancer, proliferation, apoptosis, 
tumorigenicity
Introduction
The noninvasive, real-time, and long-time imaging and tracking cancerous cells in vivo 
are of considerable interest in investigation of tumor occurrence, advances, early 
diagnosis, and treatment. In comparison with conventional organic and fluorescent 
protein probes, Quantum dots (QDs) have unique optical properties, such as high 
photoluminescence quantum yield, high intense fluorescence, excellent photostability, 
and high resistance to photobleaching and photodegradation.1–4 Especially, the recently 
developed QDs with an infrared emission wavelength between 700 and 900 nm has 
a powerful ability to penetrate human tissues and at the same time it can avoid the 
interference of tissue autofluorescence (400–600 nm), which is particularly suitable 
for noninvasive medical imaging.5–7 Currently, QDs have been used in noninvasive 
imaging of tumor cells, targeting imaging of tumor neovasculature,8–12 and detection of 
sentinel lymph nodes in live subjects through labeling tumor cells with QD,13,14 which 
demonstrate that QDs have satisfactory imaging capability in vivo. The unique optical 
properties of QDs make them appealing as in vivo fluorophores in investigation of 
tumor occurrence, advances, early diagnosis, and treatment. Recent work indicates that International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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bioconjugated QDs are nontoxic to cells and have no effect 
on cells growth and differentiation in vitro.8,15 Some studies 
used QDs labeled cancer cells for the noninvasive imaging of 
cell growth and distribution in live subject,8–14 which provides 
an important basis for the investigation of tumor occurrence, 
advances, early diagnosis, and treatment. However, the key 
issue of whether or not QDs-labeled tumor cells affect the 
proliferation, apoptosis, and in vivo tumorigenicity ability has 
not been reported. The key issue that needs to be resolved is 
if the results obtained from the noninvasive visualization of 
QDs-labeled tumors are scientific and if the results reflect 
the actual tumor cell growth and invasion in vivo.
Ninety percent of malignant tumor in the oral and 
maxillofacial regions is squamous cell carcinoma. Buccal 
squamous cell carcinoma is one of the most common oral 
squamous cell carcinomas, with only 50% to 60% survival 
rate at five years16,17 and thus investigation on this tumor is 
of high significance. Recent studies have shown that mem-
brane-penetrating peptide-conjugated QDs can label the cells 
effectively and rapidly.18–21 In this study, we used peptide-
conjugated near-infrared fluorescent QD (QtrackerTM QD800) 
with a maximal emission of 800 nm to label human buccal 
squamous cell carcinoma cell line (BcaCD885) through 
endocytosis. We then observed proliferation, apoptosis, and 
tumorigenicity ability of the QD800-labeled BcaCD885 cells 
in vivo. These results provided a theoretical basis to reveal 
if the visualized tumor cells labeled by peptide-conjugated 
near-infrared fluorescent QDs reflected the actual cancerous 
cells growth and distribution in vivo.
Materials and methods
Materials
The human buccal squamous cell carcinoma cell line 
BcaCD885 was provided by West China College of Stoma-
tology, Sichuan University (Sichuan, China). QtrackerTM 800 
Cell Labeling Kit (Invitrogen, Carlsbad, CA, USA) uses a 
custom peptide to deliver QDs into the cytoplasm of live cells 
without cell-type specificity. Laser scanning confocal micro-
scope was purchased from Leica (Tcs-sp5; Leica, Wetzlar, 
Germany). Flow cytometry machine (FACSVantage; BD, 
Franklin Lakes, NJ, USA) Low-speed refrigerated centrifuge 
(Z233MK-2) was from HERMLE, (Hosheim, Germany).
experimental animals
Five female SPF level BALB/c nu/nu substrain nude mice, 
5–6 weeks old and 19–20 g of weights, were purchased from 
the Experimental Animal Center of Chongqing Medical 
University. They were kept under the conditions of constant 
temperature and humidity, and sterile bedding, food, and 
water. They were kept under room temperature.
All experimental procedures were approved by the 
Laboratory Animal Management Committee of Experimental 
Animal Research Institute.
Labeling BcaCD885 cells with QDs
Labeling BcaCD885 cells with QD800 was performed 
according to the manufacturer’s instructions. Briefly, trypsin-
digested BcaCD885 cells were transferred into EP tube with 
1 × 106 cells and then 0.2 mL of QD800 labeling solution 
(10 nM) was added. After mixing, the cells were co-cultured 
with QD800 for 1 h and centrifuged (1,000 × g) for 5 min 
at 4°C. The supernatant medium was discarded and the cell 
pellets were washed with PBS for 2 times to remove the 
uninternalized QDs. The QD800-labeled BcaCD885 cells 
(BcaCD885/QD800) were cultured continuously for 6 h. 
And then the labeled cells were dispersed into suspension 
and the labeling efficiency was detected with flow cytometry. 
Laser-scanning confocal microscope was used to observe the 
distribution of QD within BcaCD885 cells. All the experi-
ments were repeated 3 times and the average of the labeling 
rate was calculated accordingly.
Plate clone formation assay
Cell suspension (5 × 106 cells/mL) of BcaCD885/QD800 
used for the following experiments immediately was prepared 
according to the procedure described above. Suspensions of 
BcaCD885/QD800 and BcaCD885 were seeded into two 
60 mm Petri dishes with 2 × 102 cells in each dish. The cells 
were dispersed evenly by slightly shaking the Petri dishes and 
then were incubated at 37°C with 5% of CO2 for 21 d until 
the visible clones appeared. The medium was discarded and 
the cells were carefully washed with PBS twice. After being 
fixed with methanol for 15 min, the cells were stained with 
Giemsa’s solution for 15 min before washing with tap water 
and air-drying. The clones with more than 50 cells were 
counted with an ordinary optical microscope and the clone 
formation rate was calculated with the following formula: 
Plate clone formation efficiency = (number of clones/number 
of cells inoculated) × 100%. All the experiments were 
repeated 3 times and the average values were reported.
Tumorigenicity experiment
After  labeling,  0.1  mL  of  BcaCD885/QD800  and 
BcaCD885 cells (2 × 106 cells/mL) was immediately inocu-
lated subcutaneously on the left and right backs of 5 nude 
mice. Tumorigenicity was monitored 21 d after inoculation, International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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all mice sacrificed by neck-breaking and the tumors were 
taken out and weighed. The tumor’s maximal long diam-
eter (a) and minimal short diameter (b) were measured, 
and the volume of tumor was calculated by the equation of 
V = 0.5 × a × b2. Ten tumors were saved for the following 
detection of proliferation and apoptosis.
Detection of proliferation and apoptotic 
capabilities of tumorigenic cells in vivo
Tumor cells from those 10 fresh tumor tissues (BcaCD885/
QD800 and BcaCD885 5 specimens each) were suspended, 
and their proliferation and apoptosis were analyzed by flow 
cytometry. Brief description of the experimental procedure 
is as follows: each sample was cleaned by removing the 
surrounding necrotic tissues, washed 3 times with D-Hanks 
solution, treated with penicillin (5 × 105 U/L) and strepto-
mycin (100 mg/L) for 20 min. Then each tumor was cut into 
1 mm3 pieces, which were subsequently treated with diges-
tion solution (20 mg/10 mL of collagenase, 10 mg/10 mL of 
DNase, and 0.002 mg/10 mL of Hyaluronidase) for 40 min 
and filtered with 200-mesh tantalum net. The filtered solu-
tions were centrifuged at 1000 r/min for 5 min and the pel-
lets were washed 2 times with PBS and then resuspended in 
RPMI 1640 medium to make 10 cell suspension solutions 
for flow cytometry analyses.
Detection of tumorigenic cell proliferation with 
flow cytometry: all cell concentrations were adjusted to 
1 × 106/mL and 1 mL of cell suspension solution was cen-
trifuged (1000 r/min, 4°C) for 5 min. The pelleted tumor 
cells were fixed in 70% ethanol at −20°C and then kept at 
4°C overnight. The cells were spin down by centrifuging at 
1000 r/min at 4°C for 5 min, followed by 2 times of wash-
ing with PBS and 30 min staining with PI solution at 4°C 
in dark. The following equation was used to calculate the 
proliferation index of tumor cell (PI): PI = (S + G2/M)/(G0/
G1 + S + G2/M) × 100%.
Detection of tumorigenic cell apoptosis with flow 
  cytometry: all cell concentrations were adjusted to 1 × 106/mL 
and 1 mL of cell suspension solution was centrifuged 
(1000 r/min, 4°C) for 5 min. The pelleted tumor cells 
were washed 2 times with 4°C PBS, stained in 200 µL of 
Annexin V staining solution at room temperature for 15 min 
then in 1 mL of PI staining solution for 5 min before flow 
cytometry analysis. The following equation was used to cal-
culate the apoptosis index of tumor cell (AI): AI = (number of 
apoptotic cells/total number of measured cells) × 100%.
All the experiments were repeated for 3 times and the 
average values were reported.
Statistical evaluations
A Student’s t-test was applied to analyze the data measured. 
All values are presented as means ± SD. P , 0.05 was con-
sidered statistically significant.
Results
Labeling of BcaCD885 cells with QDs
The labeling rate of BcaCD885 cells after 6 h was 
(94.37 ± 2.38%), as detected by flow cytometry. The aver-
age fluorescence intensity was 233.81 ± 7.44. After 6 h, a 
large amount of QD800 was distributed in the cytoplasm, as 
detected by a laser confocal microscope (Figure 1).
Effect of QDs on the BcaCD885 cell 
proliferation and apoptosis
The average proliferation indexes of BcaCD885/QD800 and 
BcaCD885 cells were (51.38 ± 2.75%) and (52.06 ± 2.47%), 
respectively, which are not significantly different from each 
other (P . 0.05), and their average apoptosis indexes were 
(10.22 ± 0.81%) and (9.53 ± 0.74%), respectively, which are 
also not significantly different from each other (P . 0.05). 
These results indicate that QD800 labeling does not change 
the proliferation and apoptosis of BcaCD885 cells.
Figure 1 Fluorescent images of cells labeled with QD800 after 6 h. Bright-field (A). QD800 fluorescence image (B). Overlay image (C).International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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Effect of QDs on the BcaCD885  
cell clone formation
The clone formation efficiency BcaCD885/QD800 and 
BcaCD885 cells were (64.7 ± 5.4%) and (66.2 ± 3.1%), 
respectively, after 21 d of culture (Figure 2). Statistical analy-
sis showed that there was no significant difference between 
the clonal formation rate of QDs-labeled cells and that of 
unlabeled cells, indicating that labeling of BcaCD885 cells 
with QD800 does not affect the clone forming ability.
Effect of QDs on the BcaCD885  
cell tumorigenicity in vivo
Obvious tumorigenicity was observed in both BcaCD885/
QD800 group and BcaCD885 group 21 days after the 
subcutaneous inoculation. The average weights of tumors 
of BcaCD885/QD800 group and BcaCD885 group were 
1.46 ± 0.19 g and 1.52 ± 0.21 g, respectively, which are not 
significantly different from each other (P . 0.05). The aver-
age sizes of tumors were 2.83 ± 0.74 cm³ and 2.95 ± 0.81 cm³ 
for BcaCD885/QD800 group and BcaCD885 group, respec-
tively, which are also not significant different from each 
other (P . 0.05). These results indicate that QD800 labeling 
does not change BcaCD885 cells tumorigenicity capacities 
in vivo (Figure 3).
Effect of QDs on the BcaCD885 
tumorigenic cells proliferation  
and apoptosis in vivo
Twenty one days after tumorigenesis, the average prolifera-
tion indexes of BcaCD885/QD800 and BcaCD885 tumori-
genic cells were (49.57 ± 2.06%) and (50.68 ± 2.24%), 
respectively, which are not significantly different from each 
other (P . 0.05), and their average apoptosis indexes were 
(12.63 ± 0.82%) and (11.79 ± 0.75%), respectively, which are 
also not significantly different from each other (P . 0.05). 
These results indicate that QD800 labeling does not change 
the proliferation and apoptosis capabilities of BcaCD885 
tumorigenic cells.
Discussion
In comparison with conventional organic (eg, rhodamine, 
FITC, Cy3, and Cy5) and fluorescent protein probes, QDs 
developed due to multidisciplinary cross-cutting develop-
ment and have unique optical properties, such as high pho-
toluminescence quantum yield, high intense fluorescence, 
excellent photostability, and high resistance to photobleach-
ing and photodegradation.1–4 The luminescence feature of 
QDs displays strict size effect: all kinds of spectra from 
UV to infrared wavelength or from blue to red wavelength 
can be obtained by changing the size of QDs.8 Therefore, 
live cell labeled with QDs makes it possible for long-term 
or simultaneous multicolor observation of multiple cell 
interactions. Currently, QDs have been used in noninvasive 
imaging of cancerous cells to reveal the cells growth and 
distribution in vivo.8–14 However, the issue of whether or not 
QDs affect the proliferation, apoptosis and tumorigenicity 
ability of tumor cells has not been reported. The key issue is 
precisely if the results obtained from the noninvasive visu-
alization of QDs-labeled tumors are scientific to reflect the 
growth, proliferation, apoptosis, and tumorigenicity ability 
in vivo. Our study used peptide-conjugated maximum emis-
sion wavelength 800 nm near-infrared fluorescent quantum 
dots for labeling BcaCD885 cancer cells, these experi-
ments proved that quantum dots can label BcaCD885 cells 
through entering quickly the cells, and the labeling rate of 
BcaCD885 cells after 6 h was 94.37%. QD800 labeling of 
BcaCD885 cancer cells does not affect their proliferation, 
apoptosis, and tumorigenicity ability, and offered a scien-
tific basis for in vivo the noninvasive in situ imaging of cell 
growth and distribution using near-infrared fluorescent 
quantum dots.
Figure 2 The clone formation efficiency of BcaCD885 cell treated or untreated 
with QD800 after 21 d of culture. Panel A indicated the unlabeled BcaCD885 cells 
and panel B indicated BcaCD885 labeled with QD800.
Figure  3  BcaCD885/QD800  and  BcaCD885  cells  tumorigenicity  in  vivo  was 
monitored for 21 d after cells inoculation. The left backs (L) of nude mice are 
BcaCD885/QD800 group and the rights (R) are BcaCD885 group.International Journal of Nanomedicine
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Conclusion
Peptide-linked near-conjugated fluorescent QDs labeling 
showed no effects on the growth, proliferation, apoptosis, 
and tumorigenicity ability of those cancer cells. Our study 
provides scientific foundation to support the application of 
peptide-linked near-conjugated fluorescent QDs in noninva-
sive imaging and monitoring of cancer cells in vivo.
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